[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.205.106.138. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
March 1964

Clinical and Laboratory Evaluation of Idoxuridine (IDU) Therapy in Herpes Simplex Keratitis

Author Affiliations

Chicago
From the Departments of Ophthalmology, Medicine, and Microbiology, Presbyterian-St. Luke's Hospital.

Arch Ophthalmol. 1964;71(3):325-331. doi:10.1001/archopht.1964.00970010341007
Abstract

Introduction  In 1960 Tamm1 reported that inhibitors of DNA synthesis could suppress the multiplication of herpes simplex virus in tissue culture. The treatment of herpes keratitis with idoxuridine (5-iodo-2-desoxyuridine, IDU) however, was first suggested by Kaufman.2 He and other authors have reported their generally good results in subsequent communications3-16 in experimentally induced disease in rabbits as well as in the naturally occurring infection in man. Attempts to repeat this work yielded somewhat less encouraging results in our hands and, therefore, a more extensive investigation was initiated. Our studies reported in this paper include: (1) the effect of idoxuridine on herpes keratitis in rabbits and patients, correlated with the presence or absence of demonstrable virus; (2) the influence of the immune status of rabbits on the clinical and virological course of the disease; and (3) the influence of idoxuridine on virus and host cells in a tissue culture

First Page Preview View Large
First page PDF preview
First page PDF preview
×